Pharmacy Practice

AHA, ASHP, and FAH Collaborating on Drug-Pricing Survey

Published: April 18, 2018

The American Hospital Association (AHA), ASHP, and the Federation of American Hospitals (FAH) are fielding a survey to all community hospitals and health systems to collect quantitative, representative data on pharmaceutical drug spending and the impact of drug shortages. This information is critical to our efforts to educate policymakers and the public about the challenges of high and rising drug prices and to achieve sustainable drug pricing.

The survey request was sent to either system-level CEOs or hospital CEOs, based on the AHA and FAH database. ASHP is suggesting that our members reach out to their CEOs to confirm receipt of the message and offer their assistance in completing the survey. You can view a sample of the survey invitation letter from the three organizations here. For questions about the survey, contact David Chen, Senior Director, ASHP Section of Pharmacy Practice Managers, at [email protected].

This drug-pricing survey is a follow-up to the one conducted in 2016: “Trends in Hospital Inpatient Drug Costs: Issues and Challenges.” The results of this survey will be used in continued advocacy by ASHP, AHA, and FAH with Congress, the White House, CMS, and other influencers.


Posted April 18, 2018

Advance Your Professional Development

View Other Products

Free Board Exam Prep Resources

The Review & Recertification Reward Program (RRRP) includes free access to exam preparation material + enrollment in a recertification plan billed monthly ($10) during your initial recertification cycle. For ASHP members only.

Learn More
Review & Recertification Reward Program (RRRP)

New Edition Available to Order

AHFS Drug Information® 2024 contains the most dependable drug information available—all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.

Order Today
AHFS 2024 Drug Information